Hi,
Following on from the later posts here: my time has come will start a thread dedicated to Ross discussion. Well another one. As mentioned before, both viable options in my opinion but now to choose.
Having known I'd need a valve replacement for over ten years the time is certainly close now. I was scheduled for surgery in late 2021 but for several reasons pushed it back. Previously my cardiologist had only ever discussed mechanical valves for me at age 43. Plus an ascending aorta replacement, a one and done via mech valve was on the table. First surgical consult and the Ross was put forward as an option. Primary reason, as stated, improved long term outcomes. Survival rates matched to general population. That is the claim and having researched this in some detail it seems to be the general consensus that this is likely a real a benefit of the procedure rather than a benefit derived from having a surgery at a center of excellence by a top end surgeon, having been specifically selected as suitable for this procedure. Selection is an interesting point, in my case other wise healthy , previously quite athletic, not so much for nearly 2 years or so now but suspect the likelihood of doing well with a mechanical valve is quite high also. Creature of habit and engineer so ACT management should prove no problem.
Back to the Ross, a living valve placed with particular care by a select number of surgeons in patients that have been specially selected. Apparently the autograft will alter over time and adjust so that at a cellular level it becomes more like an aortic tricuspid valve. All well and good once the root maintains it's diameter. Yet solid data to support long term results is hard to come by if non existent.. Beyond 20 years or even 15 it is not possible to make any comment with real confidence. In reality who knows what happens in 15 to 20 years anyway, one thing I do know, if you get 15 to 20 years from a Mech, chances are you'll just keep on ticking, that's my feeling, looking at the valve issue in isolation.
Pulmonary donor valve also to be considered. Suggested that at 15 to 20 years maybe 25% will need to be replaced. Some have lasted longer, this guy always amazes me ( ) 24 years and still going. Luck of the draw no doubt
Interesting at the end of this presentation the audience are asked what procedure they would opt for, most of these doctors opt for the Ross.
I've been reading about all of the options for some time now. A comment in this video was quite interesting to me, well a couple. The claim is that even with well managed ACT survival is lower in mechanical valve groups. Also an interesting comment about neurological decline due to small clots being produced. If ACT is managed correctly this should not be a problem and the 1000's of patients living long term with mechanical valves are testament to that, however i found his comment interesting.
The Ross registry in Germany/Holland also suggests benefits of a Ross Update on the German Ross Registry - Sievers- Annals of Cardiothoracic Surgery
A couple of papers included also, the numbers involved tend to be small but there are many such papers. I I recall one study combined several to bring the numbers towards 20K.. I may dig that one up if I can.
I best stop there for now. Happy new year !
P
Following on from the later posts here: my time has come will start a thread dedicated to Ross discussion. Well another one. As mentioned before, both viable options in my opinion but now to choose.
Having known I'd need a valve replacement for over ten years the time is certainly close now. I was scheduled for surgery in late 2021 but for several reasons pushed it back. Previously my cardiologist had only ever discussed mechanical valves for me at age 43. Plus an ascending aorta replacement, a one and done via mech valve was on the table. First surgical consult and the Ross was put forward as an option. Primary reason, as stated, improved long term outcomes. Survival rates matched to general population. That is the claim and having researched this in some detail it seems to be the general consensus that this is likely a real a benefit of the procedure rather than a benefit derived from having a surgery at a center of excellence by a top end surgeon, having been specifically selected as suitable for this procedure. Selection is an interesting point, in my case other wise healthy , previously quite athletic, not so much for nearly 2 years or so now but suspect the likelihood of doing well with a mechanical valve is quite high also. Creature of habit and engineer so ACT management should prove no problem.
Back to the Ross, a living valve placed with particular care by a select number of surgeons in patients that have been specially selected. Apparently the autograft will alter over time and adjust so that at a cellular level it becomes more like an aortic tricuspid valve. All well and good once the root maintains it's diameter. Yet solid data to support long term results is hard to come by if non existent.. Beyond 20 years or even 15 it is not possible to make any comment with real confidence. In reality who knows what happens in 15 to 20 years anyway, one thing I do know, if you get 15 to 20 years from a Mech, chances are you'll just keep on ticking, that's my feeling, looking at the valve issue in isolation.
Pulmonary donor valve also to be considered. Suggested that at 15 to 20 years maybe 25% will need to be replaced. Some have lasted longer, this guy always amazes me ( ) 24 years and still going. Luck of the draw no doubt
Interesting at the end of this presentation the audience are asked what procedure they would opt for, most of these doctors opt for the Ross.
I've been reading about all of the options for some time now. A comment in this video was quite interesting to me, well a couple. The claim is that even with well managed ACT survival is lower in mechanical valve groups. Also an interesting comment about neurological decline due to small clots being produced. If ACT is managed correctly this should not be a problem and the 1000's of patients living long term with mechanical valves are testament to that, however i found his comment interesting.
The Ross registry in Germany/Holland also suggests benefits of a Ross Update on the German Ross Registry - Sievers- Annals of Cardiothoracic Surgery
A couple of papers included also, the numbers involved tend to be small but there are many such papers. I I recall one study combined several to bring the numbers towards 20K.. I may dig that one up if I can.
I best stop there for now. Happy new year !
P